Targeting folate receptor alpha for cancer treatment. (2016)
Attributed to:
Preclinical efficacy of an antibody of the IgE class against a melanoma-associated antigen
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.18632/oncotarget.9651
PubMed Identifier: 27248175
Publication URI: http://europepmc.org/abstract/MED/27248175
Type: Journal Article/Review
Volume: 7
Parent Publication: Oncotarget
Issue: 32
ISSN: 1949-2553